Utpal Das

6PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTransition metal chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 02, 2024
Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy.

Utpal Das, Uttara Basu, Priyankar Paira

|Mar 21, 2024
Exploring the phototoxicity of GSH-resistant 2-(5,6-dichloro-1H-benzo[d]imidazol-2-yl)quinoline-based Ir(III)-PTA complexes in MDA-MB-231 cancer cells.

Utpal Das, Priyankar Paira

|Mar 12, 2024
Re(I)[2-aryl-1H-imidazo[4,5-f][1,10]phenanthroline] tricarbonyl chloride complexes for selective cancer therapy via a potential DNA damage mechanism.

Lavanya Thilak Babu, Utpal Das, Rishav Das

|Aug 03, 2022
Target-specific mononuclear and binuclear rhenium(i) tricarbonyl complexes as upcoming anticancer drugs.

Ajay Sharma S, Vaibhavi N, Binoy Kar

|Apr 28, 2022
Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468.

Ashaparna Mondal, Shanooja Shanavas, Utsav Sen

|Mar 16, 2022
Iridium(III)-Cp*-(imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenol analogues as hypoxia active, GSH-resistant cancer cytoselective and mitochondria-targeting cancer stem cell therapeutic agents.

Binoy Kar, Shanooja Shanavas, Apoorva H Nagendra

Pageof 1

Frequent Collaborators

6 joint publications

Priyankar Paira

3 joint publications

Binoy Kar

2 joint publications

Shanooja Shanavas

2 joint publications

Nilmadhab Roy